MAGNETOM World

Clinical Talks

Experience the talks we have captured during various Workshops and Events.

Preview Clinical Talk Adrienne Campbell-Washburn

Interventional MRI: Expanding the Boundaries of Image-Guided Therapy

2026-09-10

Afshin Gangi, M.D., Ph.D.
(Dept. of Interventional Radiology, University Hospital of Strasbourg, France).

CIRSE 2026 Lunch Symposium

Exploring the Human Brain and Fostering Collaboration with MAGNETOM Iseult 11.7T MR Scanner

2026-07-23

Franck Mauconduit, Ph.D. (Université Paris-Saclay, CEA, CNRS, BAOBAB, Neurospin, France)

OHBM 2026 Lunch Symposium

Advancing (Clinical) Insights Through Imaging of Complex Brain Structures Using 7T

2026-07-22

Roy Haast, Ph.D.

Center for Magnetic Resonance in Biology and Medicine (CRMBM), Marseille, France

Development in Quantitative MRI for Clinical Research in Neuro-Imaging at 3T

2026-07-22

Emeline J. Ribot, Ph.D. (Centre de Résonance Magnétique des Systèmes Biologiques, Université de Bordeaux, France)

OHBM 2026 Lunch Symposium

PET/MR Simultaneous Acquisitions: Proven Benefits and Applications on the Horizon

2026-07-13

Fernando E. Boada, Ph.D. (Stanford University, RSL/MIPS, Stanford, CA, USA)

SNMMI 2026, Huntington Beach, CA, USA

Whole-Body MRI at 0.55T. A Journey Spanning 5 Years and 5 Months

2026-06-30

Elmar M. Merkle, M.D. (Dept. of Radiology, University Hospital Basel, Switzerland)

ISMRM 2026 Lunch Symposium

Cardiac Stimulation Limits of Modern Gradient Systems

2026-06-25

Valerie Klein, Ph.D.

(Massachusetts General Hospital, Charlestown, MA, USA)

ISMRM 2026 Lunch Symposium

Real-life experience using a fully automated CMR planning software in a Swiss radiology department

2026-03-31

Carl Glessgen, M.D.

Geneva University Hospitals (HUG), Geneva, Switzerland

ECR 2026 Lunch Symposium

APT-CEST in Clinical Neuroimaging

2026-03-31

Daniel Paech, M.D., Ph.D.

(Brigham Research Imaging Core (BRIC), Boston, MA, USA)

ISMRM 2026 Lunch Symposium

Building a Successful PET/MR Program: Collaborative Clinical Practice and Neurodegeneration Imaging at University Hospital Ulm

2026-03-23

Meinrad Beer, M.D.; Ambros J. Beer, M.D.
(Depts. of Radiology and Nuclear Medicine, Ulm University Medical Center, Ulm, Germany)

ECR 2026 Lunch Symposium

Translating Research into Seamless Clinical Evaluation Using Open Recon

2026-01-20

Till Hülnhagen, Ph.D.
(Siemens Healthineers, Erlangen, Germany)

ESMRMB 2025 Lunch Symposium

Unlocking Innovation: gammaSTAR’s Integration with the Open Sequence Interface

2026-01-20

Daniel Christopher Hoinkiss, Dr. rer. nat.

(Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany)

ESMRMB 2025 Lunch Symposium

First Experiences with BIOGRAPH One PET/MR

2025-11-10

Kirsten Korsholm, MD, PhD. (Rigshospitalet, Copenhagen, Denmark)
EANM 2025, Barcelona, Spain

Dementia Imaging Update: Role of the Radiologist in the Era of Disease-Modifying Therapies

2025-11-10

Ana M. Franceschi, MD, PhD
(Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA)

ECR Lunch Symposium 2025
Vienna, Austra

First Impressions of the BIOGRAPH One PET/MRI at Rigshospitalet

2025-11-10

Thomas Lund Andersen, PhD, MPE
(Rigshospitalet, Copenhagen, Denmark)

ESHI CHILI 2025

The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.

The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist there can be no guarantee that other customers will achieve the same results.

Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens organization for further details.

MAGNETOM 7T and 9.4T are ongoing research. All data shown are acquired using non-commercial systems under institutional review board permission. Siemens does not intend to commercialize the systems. MAGNETOM Terra is currently under development and is not for sale in the US and in other countries. Its future availability cannot be ensured.

The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens.

MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.